Practice Areas
- FDA & Healthcare
- Pharmaceuticals & Biologics
- Medical Devices & Radiological Products
- Medicare and Medicaid Reimbursement and Payment
- Life Sciences
- False Claims Act and Qui Tam Litigation
- Privacy
- Hospitals, Health Systems, and Academic Medical Centers
- Healthcare Specialty Providers & Suppliers
- Healthcare
Bar Admissions
- District of Columbia
- New York
- Washington, D.C.
-
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5960
Fax: 202.739.3001
63 Publications Found
| Date | Title | Publication |
| 03/19/13 |
Differential Charging to medicare and Self-Pay and Commercial Payors, presented at the Institute on Medicare and Medicaid Payment Issues, Baltimore |
Speech |
| 02/28/13 |
Analyzing the Current and Possible Future Part B Reimbursement Landscape |
Speech |
| 01/28/13 |
Incentivizing Quality Improvement – Better to Appeal to ProfessionalPride or Pocketbook? |
Speech |
| 01/16/13 |
Minimizing FCA Liability Attaching to Price Reporting when Making Reasonable Assumptions, presented at the American Conference Institute’s 10th NationalRx Drug Pricing Boot Camp |
Speech |
| 09/12/12 |
Recent Part D Changes – Implications for Pharmaceutical Manufacturers, presented for FX Conferences |
Speech |
| 07/20/12 |
Massachusetts Amends Anti-Kickback Law |
Life Sciences and Healthcare LawFlash |
| June 2012 |
Manufacturers Affected by Recent Medicare Part D Rule, LMG Life Sciences 2012 |
Article |
| 2012 |
Out of Bounds: CMS Proposed Rule
for AMP Under Medicaid, PLC's Multi-Jurisdictional Guide 2012: Life Sciences |
Article |
| 05/22/12 |
Manufacturer Patient Support Initiatives: Current Practices and Recent Challenges, presented at the AHLA/FDLI's Intersecting Worlds of Drug, Device, Biologics and Health Law |
Speech |
| 04/18/12 |
Manufacturers Affected by Recent Medicare Part D Rule |
Life Sciences and Healthcare LawFlash |
| 03/29/12 |
HACs, Readmissions and VBP: Hospital Strategies for Turning Lemons into Lemonade, presented at the Institute on Medicare and Medicaid Payment Issues, Baltimore, MD |
Speech |
| 02/06/12 |
CMS Proposes Major Changes to AMP Rule |
Life Sciences and Healthcare LawFlash |
| 11/16/11 |
Avoiding Anti-Kickback Challenges Related to Pricing and Contracting, presented at the 8th National Rx Drug Pricing Boot Camp, New York |
Speech |
| 03/01/11 |
Medicare Part D and the Coverage Gap Discount Program, presented at ACI’s 9th Annual Advanced Forum on Government Regulation of Prescription Drug Pricing, New York |
Speech |
| 11/18/10 |
Understanding the Interrealtionship of Pricing Methodologies and How One Price May Affect Another, presented at ACI's Prescription Drug Pricing Boot Camp |
Speech |
| 11/15/10 |
USP to Update Medicare Model Guidelines |
FDA and Healthcare LawFlash |
| 07/06/10 |
Price Reporting and Governmental Rebate Issues Arising from the Healthcare Reform Law—an Early Assessment |
Washington Government Relations and Public Policy LawFlash |
| 04/13/10 |
Healthcare Reform Law: Issues Affecting Hospitals and Health Systems |
Washington Government Relations and Public Policy LawFlash |
| 01/23/09 |
CMS Regulation Addresses Protected Drug Categories and Classes |
FDA and Healthcare LawFlash |
| 06/29/08 |
Off-Label Use of Drugs and Devices, presented at the American Health Lawyers Association's 2008 In-House Counsel Program & Annual Meeting, San Francisco |
Speech |
| 11/15/07 |
Implications of CMS Clinical Research Policy, presented as a webinar for The Center for Business Intelligence |
Speech |
| 07/18/07 |
CMS Proposes Changes to Its Policies Governing Off-Label Uses of Anticancer Drugs and Biologicals |
FDA and Healthcare LawFlash |
| 03/22/07 |
The Patient's Nose Under the Tent: The Impact on Hospitals of State and Federal Healthcare Transparency Initiatives, presented at the American Health Lawyers Association's Institute on Medicare and Medicaid Payment Issues, Baltimore |
Speech |
| 03/21/07 |
2006: The RAP Practice Group's Year in Review, presented at the American Health Lawyers Association's Institute on Medicare and Medicaid Payment Issues, Baltimore |
Speech |
| 03/02/07 |
Potential Challenges to Pricing of Biotech Products: Medicare/Medicaid and Related Pricing Developments, presented at the 2007 BIO General Counsels' Committee Meeting |
Speech |
| May 2006 |
DRA May Drive New Relationships, Reimbursement Advisor, Vol. 21, No. 10 |
Article |
| 03/01/06 |
Year in Review, presented at the Medicare and Medicaid Institute, American Health Lawyers Association |
Speech |
| February 2006 |
OIG 2006 Work Plan, Reimbursement Advisor, Vol. 21, No. 7 |
Article |
| 01/01/06 |
Compliance Issues Relating to Providing Discounts to the Uninsured, presented at the HCCA 2005 South Atlantic Area Compliance Conference |
Speech |
| 01/01/06 |
Graduate Medical Education (GME) Reimbursement Issues, Legal Issues Affecting Academic Medical Centers and Other Teaching Institutions, presented at the American Health Lawyers Association |
Speech |
| January 2006 |
Implementation of the Part D Drug Benefit, Reimbursement Advisor, Vol. 21, No. 6 |
Article |
| December 2005 |
Novel CMS Decision on Beneficiary "Upgrades", Reimbursement Advisor, Vol. 21, No. 5 |
Article |
| September 2005 |
"Questionable" Guidance, Journal of Healthcare Financial Management |
Article |
| 09/01/05 |
Compliance Issues Relating to Providing Discounts to the Uninsured, presented at the HCCA 2005 Northeast Area Compliance Conference |
Speech |
| June 2005 |
"CMS" GME Clarifications, Reimbursement Advisor, Vol. 20, No. 11 |
Article |
| March 2005 |
MMA and Beyond: The Regulation, Accreditation, and Payment Practice Group’s Update, presented at the Medicare Medicaid Institute, American Health Lawyers Association |
Speech |
| 11/01/04 |
Price Reporting Compliance: Best Practices in Reporting Medicaid Drug Rebate Program and Part B ASP Data, presented at the Pharmaceutical Compliance Forum’s Fifth Annual Pharmaceutical Regulatory & Compliance Congress |
Speech |
| October 2004 |
CMS Revises MSP Requirements for Reference Laboratory Services, Reimbursement Advisor, Vol. 20, No. 2 |
Article |
| 10/01/04 |
The MMA and its Implementation: 10 Opportunities for the Diligent and 10 Pitfalls for the Unwary, presented at the New Jersey Chapter Healthcare Financial Management Association |
Speech |
| 09/01/04 |
Distinguishing the 800-Pound Compliance Gorillas from the Featherweights: An Analysis of the Weight of Various Regulatory Authorities, presented at the Fraud and Compliance Forum, American Health Lawyers Association |
Speech |
| July 2004 |
Medicare Implications of Hospital Discounts to the Uninsured, Journal of Healthcare Management |
Article |
| March 2004 |
Medicaid Provisions in MMA, Reimbursement Advisor, Vol. 19, No. 8 |
Article |
| 03/01/04 |
Significant Provisions of the MMA: Part A and Related Provisions, presented at the Medicare and Medicaid Institute, American Health Lawyers Association |
Speech |
| 02/01/04 |
New Opportunities for Drugs Under Old Medicare: Changes to Inpatient New Technology Pass-Throughs and "Incident to" Coverage, presented at the National Medicare Prescription Drug Congress |
Speech |
| January 2004 |
Reimbursement for Residents Training Offsite Under Volunteer Physicians, Reimbursement Advisor, Vol. 19, No. 6 |
Article |
| 11/01/03 |
Outlier Update, presented at the HCCA Mid-Atlantic Conference |
Speech |
| 09/01/03 |
Achieving Best Practices in Teaching Physician Billing and Supervision, presented at the American Health Lawyers Association Fraud and Compliance Forum |
Speech |
| May 2003 |
CMS’s Proposed Outlier Regulation, Reimbursement Advisor, Vol. 18, No. 10 |
Article |
| 05/01/03 |
New Technology Adjustment Under the DRG Payment System, presented at The Future of Medicare Policy for Medical Technologies |
Speech |
| 04/01/03 |
Charges – Why Are They Still Relevant, presented at the Medicare Medicaid Institute, American Health Lawyers Association |
Speech |
| 02/01/03 |
What Every Compliance Officer Should Know About Coding Evaluation and Management Services Furnished by Physicians and Hospitals, presented at the 6th Annual National Congress on Health Care Compliance |
Speech |
| 10/01/02 |
APC Coding Update, presented at the HCCA Mid-Atlantic Conference |
Speech |
| 05/01/02 |
Compliance in Writing RFP Responses and Sales Agreements to Purchase a Product from a Referral Source, presented at the Region IV of the Healthcare Financial Management Association |
Speech |
| 02/01/02 |
Significant Recent Developments in APCs, presented at the Colorado Chapter of the Healthcare Financial Management Association |
Speech |
| 02/01/02 |
The Fundamentals of Coding for Non-Coders and Potential Compliance Issues Related to Coding Activities, presented at the 5th Annual National Congress on Health Care Compliance |
Speech |
| 02/01/02 |
The Fundamentals of Coding for Non-Coders and Potential Compliance Issues Related to Coding Activities, presented at the Health Care Compliance Association Annual Compliance Institute |
Speech |
| January 2002 |
CMS Reverses Policy Regarding 5.8 Percent Reduction in Inpatient Ancillary Services, Reimbursement Advisor, Vol. 17, No. 5 |
Article |
| January 2002 |
OIG's Position on "Prebates", Reimbursement Advisor, Vol. 17, No. 5 |
Article |
| November 2001 |
Affiliation Agreements for GME Residency Programs, Reimbursement Advisor, Vol. 17, No. 3 |
Article |
| November 2000 |
Recoupment of Medicare Overpayments from Providers in Bankruptcy, Reimbursement Advisor, Vol. 16, No. 3 |
Article |
| 1999 |
Empowering Patients to Act Like Consumers: A Proposal Creating Price and Quality Choice within Health Care, Saint John’s Law Review, Vol. 73 |
Article |
| 1997 |
Capitation: The Legal Implications of Using Capitation to Affect Physician Decision-Making Processes, The Journal of Contemporary Health Law and Policy, Vol. 13 |
Article |
| 1996 |
Unbridled Managed Care: When Consumers Experience Antitrust Welfare Loss From Exclusionary Contracts Between HMO Insurers and Health Care Providers, Health Matrix, Vol. 6 |
Article |
